Viyash has ten manufacturing facilities in India with a combined capacity of 2000 KL as well as one formulation facility in the US, and is now one of India’s leading mid-tier integrated API and formulation players
The cream has an estimated market size of US $ 28 million for twelve months ending Jun 2021 according to IQVIA
The company has operations in North America, Asia, and Europe,
The drug helps in managing cholesterol
Venus Remedies has reported consolidated financial results for the period ended September 30, 2021
The injunction order has been passed against Natco Pharma, Torrent Pharmaceuticals, Eris Lifesciences and Windlas Biotech
The Akovaz brand and generic market had U.S. sales of approximately US $ 67.5 million MAT for the most recent twelve months ending in August 2021
Dr. Reddy's Laboratories has reported consolidated financial results for the period ended September 30, 2021
In India, MSD has signed non-exclusive licensing agreements with eight pharma companies.
FDI increased 98% year on year in 2020 and pharma exports grew by 18% in the last financial year
Subscribe To Our Newsletter & Stay Updated
